Why is Medi Assist Healthcare Services Ltd falling/rising?

Recent Price Performance and Market Comparison

The stock has underperformed significantly relative to the broader market benchmarks. Over the past week, Medi Assist’s shares have declined by 5.04%, compared to a modest 0.75% fall in the Sensex. Year-to-date, the stock has lost 7.98%, while the Sensex has only retreated by 2.32%. More strikingly, over the last twelve months, the stock has plunged 29.50%, in stark contrast to the Sensex’s gain of 8.65%. This underperformance extends to longer-term horizons as well, with the stock lagging the BSE500 index over one and three-year periods.

On the day in question, the stock touched an intraday low of ₹422, representing a 3.23% decline. It has also been trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum. Investor participation has waned, with delivery volumes on 16 Jan falling by 46.05% compared to the five-day average, indicating reduced buying interest amid the sell-off.

Fundamental Challenges Weighing on the Stock

Despite Medi Assist’s strong long-term fundamentals, including an average Return on Equity (ROE) of 14.05%, recent financial indicators have raised concerns among investors. Interest expenses for the nine-month period have surged by 182.12% to ₹16.73 crores, signalling increased financial costs that could pressure profitability. The operating profit to interest ratio has dropped to a low of 5.23 times, suggesting that earnings before interest and taxes are becoming less sufficient to cover interest obligations.

Moreover, profit before tax excluding other income (PBT less OI) for the latest quarter has fallen sharply by 51.0% compared to the average of the previous four quarters, highlighting a significant decline in core profitability. Although the company’s profits have risen by 5% over the past year, this improvement has not translated into positive returns for shareholders, as the stock price has declined substantially.

Valuation and Market Sentiment

Medi Assist’s valuation remains elevated, with a price-to-book value of 5.4, which is considered very expensive given the current earnings trajectory. While the stock is trading at a discount relative to its peers’ historical valuations, the high valuation multiple combined with weakening profitability metrics has likely contributed to the negative sentiment. Investors appear cautious, reflected in the stock’s consistent underperformance relative to sector peers and broader indices.

Investor Outlook and Conclusion

The recent decline in Medi Assist Healthcare Services Ltd’s share price is primarily attributable to a combination of deteriorating profitability, rising interest costs, and a stretched valuation multiple. The stock’s consistent underperformance against the Sensex and sector benchmarks over multiple time frames underscores the challenges it faces in regaining investor confidence. Reduced trading volumes and sustained weakness below key moving averages further reinforce the bearish technical outlook.

While the company maintains a respectable ROE and has delivered modest profit growth, these positives have been overshadowed by the sharp fall in core earnings and the rising cost of debt. Investors are likely to remain cautious until there is clear evidence of stabilisation in profitability and a more attractive valuation. For now, the stock’s downward trajectory appears to be driven by fundamental concerns and subdued market sentiment.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →